sulfadiazine has been researched along with Cranial Nerve II Diseases in 2 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banta, JT | 1 |
| Davis, JL | 1 |
| Lam, BL | 1 |
| Lee, MW | 1 |
| Fong, KS | 1 |
| Hsu, LY | 1 |
| Lim, WK | 1 |
2 other studies available for sulfadiazine and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Presumed toxoplasmosic anterior optic neuropathy.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male | 2002 |
Optic nerve toxoplasmosis and orbital inflammation as initial presentation of AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Blepharitis; CD4 Lymphocyte Count; Co | 2006 |